PGEN Operating Cash Flow
-$114.17MTTM · USD
Period ending:
PGEN FY Operating Cash FlowUSD
$35.67M-$124.24M
2011-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
PGEN operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -87,831,000 | |
| -68,173,000 | |
| -66,930,000 | |
| -65,045,000 | |
| -55,771,000 | |
| -77,021,000 | |
| -77,021,000 | |
| -124,240,000 | |
| -104,139,000 | |
| -55,975,000 | |
| 35,669,000 | |
| -19,858,000 | |
| -53,683,000 | |
| -61,529,000 | |
| -81,758,000 |
Compare operating cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating cash flow
- Bridgebio Pharma Inc (BBIO) operating cash flow
- Brightspring Health Services Inc (BTSG) operating cash flow
- Madrigal Pharmaceuticals Inc (MDGL) operating cash flow
- Ensign Group Inc (ENSG) operating cash flow
- Glaukos Corp (GKOS) operating cash flow
- Vaxcyte Inc (PCVX) operating cash flow
- Krystal Biotech Inc (KRYS) operating cash flow
All PGEN financial metrics · PGEN stock overview · How to interpret financial metrics